LAMB2 and neoplasm: Using a scFv (L36) that recognizes an angiogenesis-associated laminin epitope [21] and inhibits tumor angiogenesis and growth [20], we demonstrated that locally produced trimeric L36 was more effective than its monomeric counterparts in blocking capillary morphogenesis in vitro, and in preventing tumor growth in vivo[15].